LLY

1,020.07

-1.55%↓

JNJ

244.95

+0.71%↑

ABBV

228.53

-1.79%↓

NVS

165.17

-0.6%↓

MRK

121.6

+0.04%↑

LLY

1,020.07

-1.55%↓

JNJ

244.95

+0.71%↑

ABBV

228.53

-1.79%↓

NVS

165.17

-0.6%↓

MRK

121.6

+0.04%↑

LLY

1,020.07

-1.55%↓

JNJ

244.95

+0.71%↑

ABBV

228.53

-1.79%↓

NVS

165.17

-0.6%↓

MRK

121.6

+0.04%↑

LLY

1,020.07

-1.55%↓

JNJ

244.95

+0.71%↑

ABBV

228.53

-1.79%↓

NVS

165.17

-0.6%↓

MRK

121.6

+0.04%↑

LLY

1,020.07

-1.55%↓

JNJ

244.95

+0.71%↑

ABBV

228.53

-1.79%↓

NVS

165.17

-0.6%↓

MRK

121.6

+0.04%↑

ResMed Inc

Затворен

СекторЗдравеопазване

258.83 1.53

Преглед

Промяна на цената на акция

24 ч

Текуща

Минимум

255.9

Максимум

262.01

Ключови измерители

By Trading Economics

Приходи

44M

393M

Продажби

87M

1.4B

P/E

Средно за сектора

25.005

110.024

Дивидентна доходност

0.92

Марж на печалбата

27.593

Служители

10,600

EBITDA

63M

566M

Препоръки

By TipRanks

Препоръки

Купи

12-месечна прогноза

+19.04% upside

Дивиденти

By Dow Jones

Дивидентна доходност

Средно за сектора

0.92%

2.26%

Следващи печалби

22.04.2026 г.

Следваща дата на дивидент

19.03.2026 г.

Следваща дата на екс-дивидент

7.05.2026 г.

Пазарни показатели

By TradingEconomics

Пазарна капитализация

-426M

37B

Предишно отваряне

257.3

Предишно затваряне

258.83

Настроения в новините

By Acuity

23%

77%

54 / 351 Класиране в Healthcare

ResMed Inc Графика

Миналото представяне не гарантира бъдещи резултати.

Свързани новини

18.02.2026 г., 22:31 ч. UTC

Печалби

Brambles Raises Dividend, Cash-Flow Guidance as 1st Half Profit Jumps -- Update

18.02.2026 г., 22:18 ч. UTC

Печалби

Wal-Mart de Mexico 4Q Profit Falls, Hit by Higher Taxes

18.02.2026 г., 22:11 ч. UTC

Печалби

Wesfarmers Boosts Dividend After 1st Half Profit Rises -- Update

18.02.2026 г., 21:52 ч. UTC

Печалби

Telstra Boosts Dividend as First-Half Earnings Rise 5.5% -- Update

18.02.2026 г., 23:56 ч. UTC

Пазарно говорене

Santos's Review of Domestic Assets Could Lead to Simpler Portfolio -- Market Talk

18.02.2026 г., 23:46 ч. UTC

Пазарно говорене

Global Forex and Fixed Income Roundup: Market Talk

18.02.2026 г., 23:46 ч. UTC

Пазарно говорене

Nikkei May Rise After U.S. Tech Stock Gains -- Market Talk

18.02.2026 г., 23:34 ч. UTC

Пазарно говорене
Печалби

Brambles' Cost Control Stands Out to Bull -- Market Talk

18.02.2026 г., 23:33 ч. UTC

Пазарно говорене

Gold Edges Higher Amid Growing Risks of U.S.-Iran Conflict -- Market Talk

18.02.2026 г., 23:32 ч. UTC

Пазарно говорене

Australia Jobs Data Will Likely Support May Hike Assumptions -- Market Talk

18.02.2026 г., 22:45 ч. UTC

Печалби

DoorDash Stock Rebounds. Earnings and Revenue Both Fall Short. -- Barrons.com

18.02.2026 г., 22:44 ч. UTC

Пазарно говорене

Investors Eyeing Nvidia's Revenue Visibility Ahead of 4Q Print -- Market Talk

18.02.2026 г., 22:37 ч. UTC

Печалби

Nutrien 4Q EPS $1.18 >NTR.T

18.02.2026 г., 22:37 ч. UTC

Печалби

Nutrien 4Q Sales $5.34B >NTR.T

18.02.2026 г., 22:35 ч. UTC

Печалби

Pan American Silver 4Q EPS $1.07 >PAAS

18.02.2026 г., 22:35 ч. UTC

Печалби

Pan American Silver 4Q Rev $1.18B >PAAS

18.02.2026 г., 22:30 ч. UTC

Печалби

Kinross Gold Raises Quarterly Dividend to 4c Vs. 3.5c >K.T

18.02.2026 г., 22:29 ч. UTC

Печалби

Kinross Gold 4Q EPS 75c >K.T

18.02.2026 г., 22:22 ч. UTC

Печалби

Coeur Mining: Full-Yr 2026 Production Is Expected to Be 55,000 - 65,000 Ounces of Gold and 5.5M - 6.3M Ounces of Silver >CDE

18.02.2026 г., 22:22 ч. UTC

Пазарно говорене

Nvidia 4Q Earnings Coming Amid China Export Battle -- Market Talk

18.02.2026 г., 22:16 ч. UTC

Печалби

Brambles Raises Dividend, Cash-Flow Guidance as 1H Profit Jumps -- Update

18.02.2026 г., 22:05 ч. UTC

Печалби

Pan American Silver Reports Record Fourth Quarter And Full Year 2025 Financial Results; Record Cash Flow From Operations Of $554 Million In The Fourth Quarter; Dividend Increased By 29% >PAAS

18.02.2026 г., 22:03 ч. UTC

Печалби

Kaiser Aluminum Expects to Improve Conversion Rev by 5% to 10% and Adj EBITDA by 5% to 15% for FY26 >KALU

18.02.2026 г., 22:02 ч. UTC

Печалби

Kaiser Aluminum 4Q Adj EPS $1.53 >KALU

18.02.2026 г., 22:02 ч. UTC

Печалби

Kaiser Aluminum 4Q Sales $929M >KALU

18.02.2026 г., 22:02 ч. UTC

Печалби

Kaiser Aluminum 4Q EPS $1.68 >KALU

18.02.2026 г., 22:00 ч. UTC

Печалби

Kinross Gold 4Q Adj EPS 67c >KGC

18.02.2026 г., 22:00 ч. UTC

Печалби

Kinross Gold 4Q Sales $2.02B >KGC

18.02.2026 г., 21:56 ч. UTC

Печалби

Wesfarmers Boosts Dividend After 1H Profit Rises -- Update

18.02.2026 г., 21:50 ч. UTC

Пазарно говорене

Tech, Media & Telecom Roundup: Market Talk

Сравнение с други в отрасъла

Ценова промяна

ResMed Inc Прогноза

Ценова цел

By TipRanks

19.04% нагоре

12-месечна прогноза

Среден 300.64 USD  19.04%

Висок 345 USD

Нисък 265 USD

Според 13 анализатори от Wall Street, предложили 12-месечна ценова цел за ResMed Inc през последните три месеца.

Консенсусна оценка

By TipRanks

Купи

13 ratings

8

Купи

5

Задържане

0

Продай

Настроение

By Acuity

54 / 351 Класиране в Здравеопазване

Настроения в новините

Много силни бичи доказателства

Волатилност

Под средното

Обем новини (RCV)

Над средното

Финанси

Продажбени и админисративни разходи

Оперативни разходи

Печалба преди облагане с данъци

Продажби

Разходи за продажби

Брутна печалба от продажби

Разходи за лихви по дълг

EBITDA

Оперативна печалба

$

Относно ResMed Inc

ResMed Inc. develops, manufactures, distributes, and markets medical devices and cloud-based software applications for the healthcare markets. The company operates in two segments, Sleep and Respiratory Care, and Software as a Service. It offers various products and solutions for a range of respiratory disorders, including ApneaLink Air, a portable diagnostic device that measures oximetry, respiratory effort, pulse, nasal flow, and snoring; and NightOwl, a portable, cloud-connected, and disposable diagnostic device that measures AHI based on derived peripheral arterial tone, actigraphy, and oximetry over several nights. The company also provides AirView, a cloud-based system that enables remote monitoring and changing of patients' device settings; myAir, a personalized therapy management application for patients with sleep apnea that provides support, education, and troubleshooting tools for increased patient engagement and improved compliance; U-Sleep, a compliance monitoring solution that enables home medical equipment (HME) to streamline their sleep programs; connectivity module and propeller solutions; and Propeller portal. It offers out-of-hospital software solution, such as Brightree business management software and service solutions to providers of HME, pharmacy, home infusion, orthotics, and prosthetics services; MatrixCare care management and related ancillary solutions to senior living, skilled nursing, life plan communities, home health, home care, and hospice organizations, as well as related accountable care organizations; HEALTHCAREfirst that offers electronic health record, software, billing and coding services, and analytics for home health and hospice agencies; and MEDIFOX DAN's software solutions. The company markets its products to sleep clinics, home healthcare dealers, and hospitals through a network of distributors and direct sales force. ResMed Inc. was founded in 1989 and is headquartered in San Diego, California.
help-icon Live chat